Keyphrases
Breast Cancer
100%
Genetic Polymorphism
100%
Aromatase Inhibitors
100%
Body Composition Changes
100%
CYP19A1 Gene
100%
Body Composition
80%
Polymorphism
60%
Estrogen Receptor-positive Breast Cancer
60%
Postmenopausal Women
40%
GC Genotype
40%
Aromatase Inhibitor Therapy
40%
No Significant Difference
20%
Single nucleotide Polymorphism
20%
Disease-free Survival
20%
Radioimmunoassay
20%
Genotype
20%
Metabolic Abnormalities
20%
Fat-free Mass
20%
Bone Loss
20%
Dual-energy X-ray Absorptiometry
20%
Significant Loss
20%
TaqMan
20%
Third Generation
20%
Estrogen Deficiency
20%
Aromatase Gene
20%
Serum Estradiol
20%
Fat Mass Index
20%
Estradiol Level
20%
Allelic Discrimination Assay
20%
Body Composition Assessment
20%
Fat-free Mass Index
20%
Truncal Fat
20%
CYP19A1
20%
Truncal Fat Mass
20%
Biochemistry, Genetics and Molecular Biology
Body Composition
100%
Aromatase Inhibitor
100%
Aromatase
100%
Genetic Polymorphism
100%
Estrogen Receptor
42%
Genotyping
42%
Postmenopause
28%
Fat Free Mass
28%
Fat Mass
14%
Single-Nucleotide Polymorphism
14%
Allele
14%
Prospective Study
14%
Osteolysis
14%
Disease Free Survival
14%
TaqMan
14%
Estradiol Blood Level
14%
Estradiol
14%
Deficiency
14%
Medicine and Dentistry
Breast Cancer
100%
Genetic Polymorphism
100%
Aromatase
100%
Aromatase Inhibitor
100%
Estrogen Receptor Positive Breast Cancer
42%
Postmenopause
28%
Diethylstilbestrol
28%
Single Nucleotide Polymorphism
14%
Prospective Study
14%
Allele
14%
Radioimmunoassay
14%
Osteolysis
14%
Disease Free Survival
14%
Estrogen Deficiency
14%
Absorptiometry
14%
Nursing and Health Professions
Breast Cancer
100%
Body Composition
100%
Aromatase
100%
Aromatase Inhibitor
100%
Estrogen Receptor Positive Breast Cancer
42%
Fat Free Mass
28%
Fat Mass
14%
Disease Free Survival
14%
Diethylstilbestrol
14%
Absorptiometry
14%
Radioimmunoassay
14%
Estradiol Blood Level
14%
Estrogen Deficiency
14%
Immunology and Microbiology
Body Composition
100%
Genetic Polymorphism
100%
Aromatase
100%
Postmenopause
25%
Fat Free Mass
25%
Allele
12%
Disease Free Survival
12%
Radioimmunoassay
12%
Single Nucleotide Polymorphism
12%
Osteolysis
12%
Fat Mass
12%
Estradiol Blood Level
12%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Aromatase
100%
Aromatase Inhibitor
100%
Estrogen Receptor Positive Breast Cancer
42%
Diethylstilbestrol
28%
Prospective Study
14%
Disease Free Survival
14%
Radioimmunoassay
14%
Estrogen Deficiency
14%